Age disparities in survival from lymphoma and myeloma: a comparison between US and England

Dianne Pulte, Theresa Redaniel, Lisa Lowry, Jenny Bird, Mona Jeffreys

Research output: Contribution to journalArticle (Academic Journal)

13 Citations (Scopus)

Abstract

Population-level survival in older patients with lymphoma is significantly lower than in younger patients. In this study, data were obtained from cancer registries in England and the United States (US) for patients diagnosed with Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) and myeloma. Five-year relative survival was calculated using period analysis. Generalised linear models were used to determine excess hazard ratios (EHR) for older compared to younger patients. Five-year relative survival was lower for older patients diagnosed with HL, NHL and myeloma in both countries. The greatest age-related survival inequality was observed for patients with HL: in 2006-10 the EHR comparing patients aged 75 + years with those aged 15-24 years was 14·02 in the US and 15·69 in England. For NHL, the EHR was 1·91 in the US and 3·81 in England. For myeloma, comparing patients aged 75 + years with those aged 25-44 years, the EHR was 2·79 in the US and 3·60 in England. Survival of patients with lymphoma is lower for older patients in both the US and England but the discrepancy is less in the US. Physicians should be encouraged to evaluate patients' frailty and co-morbidities as well as their age when considering treatment options for patients with lymphoma and myeloma.
Original languageEnglish
Pages (from-to)824-831
Number of pages8
JournalBritish Journal of Haematology
Volume165
Issue number6
Early online date29 Mar 2014
DOIs
Publication statusPublished - Jun 2014

Keywords

  • non-hodgkin lymphoma
  • hodgkin lymphoma
  • multiple myeloma
  • survival
  • disparity

Fingerprint Dive into the research topics of 'Age disparities in survival from lymphoma and myeloma: a comparison between US and England'. Together they form a unique fingerprint.

Cite this